Atala A, Lanza R, Thompson J, Nerem R. Principles of regenerative medicine, Academic Press is an imprint of Elsevier, First edition, 2008.
Биология стволовых клеток и клеточные технологии: учебное пособие. Под редакцией М.А. Пальцева. М.: Медицина, Шик, 2009. Том 1 и 2. Biologia stvolovykh kletok i kletochniye tekhnologii: uchebnoye posobiye. Pod redaktsiyey M.A. Paltseva. M.: Meditsina, Shik, 2009. Tom 1 i 2.
Биосовместимые материалы: учебное пособие. Под ред. В.И. Севастьянова, М.П. Кирпичникова. М.: МИА, 2011. Biosovmestimiye materialy: uchebnoye posobiye. Pod redaktsiyey V.I. Sevastianova, M.P. Kir- pichnikova. М.: МIА, 2011.
Atala A, Baue SB, Soker S, Yoo JJ, Retik AB. Tissue-en- gineered autologous bladders for patients needing cysto- plasty. Lancet. 2006; 367: 1241–1247.
Macchiarini P, Jungebluth P, Go T. Clinical transplan- tation of a tissue-engineered airway. Lancet. 2008; 372: 2023–2028.
Gan MJ, Albanese-O'Neill A., Haller MJ. Type 1 diabe- tes: current concepts in epidemiology, pathophysiology, clinical care, and research. Curr. Probl. Pediatr. Adolesc. Health Care. 2012; 42: 269–291.
Shapiro A, Lakey J. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med. 2000; 343: 230–238.
Ryan EA, Lakey JRT, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005; 54: 2060– 2069.
Wahren J, Johansson B-L, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia. 1996; 37, suppl. 2: 99–107.
Шумаков ВИ, Скалецкий НН. Трансплантация ост- ровковых клеток поджелудочной железы. Трансплан- тология: руководство для врачей. Под ред. В.И. Шу- макова. М.: МИА, 2006: 418–430. Shumakov VI, Skaletskiy NN. Transplantatsia ostrovkovykh kletok po- dzheludochnoy zhelezy. Transplantologia: rukovodstvo dla vrachey. Pod red. VI. Shumakova. М.: MIA, 2006: 418–430.
Amer LD, Mahoney MJ, Bryant SJ. Tissue Engineering Approaches to Cell-Based Type 1 Diabetes. Therapy Tis- sue Engineering Part B: Reviews. October 2014; 20 (5): 455–467. doi: 10.1089/ten.teb.2013.0462.
.Bosco D, Armanet M, Morel P, Niclauss N. Unique ar- rangement of α- and β-cells in human islets of Langer- hans. Diabetes. 2010; 59.
Cabrera O. The unique cytoarchitecture of human pan- creatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 2334–2339.
Dufrane D, Gianello P. Pig islet for xenotransplantation in human: structural and physiological compatibility for human clinical application. Transplant. Rev. (Orlando). 2012; 26: 183–188.
Шрейбер В. Патофизиология желез внутренней сек- реции. Прага: Медицинское издательство, 1987: 414. Shreiber V. Patofiziologia zhelez vnutrenney sekretsii. Praga: Meditsinskoye izdatelstvo, 1987: 414.
Marigliano M, Bertera S, Grupillo M, Trucco M, Bot- tino R. Pig-to-nonhuman primates pancreatic islet xe- notransplantation: an overview. Curr. Diab. Rep. 2011; 11: 402–412.
Dufrane D, Gianello P. Macro- or microencapsulation of pig islets to cure type 1 diabetes. World J. Gastroenterol. 2012; 18: 6885–6893.
Van der Windt DJ. Clinical Islet Xenotransplantation: How Close Are We? Diabetes. 2012; 61: 3046–3055.
Sumi S, Gu Y, Hiura A, Inoue K. Regenerative medicine for insulin deficiency; creation of pancreatic islets and bioartificial pancreas. J. Hepatobiliary Pancreat. Sci. 2011; 18 (1): 6–12.
Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science. 2001; 292: 1389–1394.
Aguayo-Mazzucato C, Bonner-Weir S. Stem cell therapy for type 1 diabetes mellitus. Nat. Rev. 2010; 6: 139–149.
D'Amour K, Bang AG, Eliazer S. Production of pan- creatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol. 2006; 24: 1392– 1311.
Shi Y. Generation of functional insulin-producing cells from human embryonic stem cells in vitro. Methods Mol. Biol. 2010; 636: 79–85.
Chandra V, Phadnis S, Nair P.D, Bhonde RR. Generati- on of pancreatic hormone-expressing islet-like cell ag- gregates from murine adipose tissue-derived stem cells. Stem. Cells. 2009; 27: 1941–1945.
Basford CL. The functional and molecular characteri- sation of human embryonic stem cell-derived insulin- positive cells compared with adult pancreatic beta cells. Diabetologiа. 2012; 55: 358–371.
Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat. Rev. Immunol. 2008 Sep; 8 (9): 726–736. doi: 10. 1038/nri2395.
Milanesi A. В-Cell regeneration mediated by human bone marrow mesenchymal stem cells. PLoSOne. 2012; 7: e42177.
Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, Atkinson MA, Yang LJ. In vivo and in vitro characterizati- on of insulin-producing cells obtained from murine bone marrow. Diabetes. 2004; 53: 1721–1732.
Chen L-B, Jiang X-B, Yang L. Differentiation of rat mar- row mesenchymal stem cells into pancreatic islet beta- cells. World J. Gastroenterol. 2004; 10: 3016–3020.
17.Kroon E, Martinson LA, Kadoya K. Pancreatic endo- derm derived from human embryonic stem cells gene- rates glucose-responsive insulin-secreting cells in vivo. Nat. Biotechnol. 2008; 26: 443–451.
Gabr MM, Sobh MM, Zakaria MM, Refaie AF, Gho- neim MA. Transplantation of insulin-producing clusters derived from adult bone marrow stem cells to treat dia- betes in rats. Exp. Clin. Transplant. 2008; 6: 236–241.
Chiou SH, Chen SJ, Chang YL. A promotes the repro- gramming of placenta-derived multipotent stem cells into pancreatic islets-like and insulin-positive cells. J. Cell Mol. Med. 2010; Feb: 16–22.
Brnardo AS, Cho CH, Mason S. Biphasic induction of Pdx 1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells. Stem. Cells. 2009; 27: 341–349.
Niknamasl A, Ostad SN, Soleimani M, Azami M, Sal- mani MK, Lotfibakhshaiesh N et al. A new approach for pancreatic tissue engineering: human endometrial stem cells encapsulated in fibrin gel can differentiate to pan- creatic islet beta-cell. Cell Biol. Int. 2014 Oct; 38 (10): 1174–1182. doi: 10.1002/cbin.10314. Epub 2014 Jul 3.
Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Ol- son SD, D.J. Multipotent stromal cells from human mar- row home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 17438–17443.
Chang C. Mesenchymal stem cells adopt beta-cell fate upon diabetic pancreatic microenvironment. Pancreas. 2009; 38: 275–281.
Franquesa M, Hoogduijn MJ, Bestard O, Grinyу JM. Immunomodulatory effect of mesenchymal stem cells on B cells. Front. Immunol. 2012; 3: 212.
Hematti P, Kim J, Stein AP, Kaufman D. Potential role of mesenchymal stromal cells in pancreatic islet transplan- tation. Transplant. Rev. (Orlando). 2013; 27: 21–29.
Jun Y, Kang AR, Lee JS, Park S-J, Lee DY, Moon S-H. Microchip-based engineering of super-pancreatic islets supported by adipose-derived stem cells. Biomaterials. 2014; 35: 4815–4826.
Baeyens L, De Breuck S, Lardon J, Mfopou JK, Roo- man I, Bouwens L. In vitro generation of insulin-pro- ducing beta cells from adult exocrine pancreatic cells. Diabetologia. 2005; 48: 49–57.
Song K-H. In vitro transdifferentiation of adult pancrea- tic acinar cells into insulinexpressingcells. Biochem. Biophys. Res. Commun. 2004; 316: 1094–1100.
Minami K, Seino S. Pancreatic acinar-to-beta cell trans- differentiation in vitro. Front. Biosci. 2008; 1: 5824– 5837.
Yamada S, Yamamoto Y, NagasawaM. In vitro transdiffe- rentiation of mature hepatocytes into insulin-producing cells. Endocr. J. 2006; 53: 789–795.
Aviv V. Exendin-4 promotes liver cell proliferation and enhances the PDX-1-induced liver to pancreas transdif- ferentiation process. J. Biol. Chem. 2009; 284: 33509– 33520.
Lu Y, Li Y. Transdifferentiation of hepatic oval cells into pancreatic islet beta-cells. Front. Biosci. 2012; 17: 2391–2395.
Ulrich AB, Schmied BM, Standop J, Schneider MB, Pour PM. Pancreatic celllines: a review. Pancreas. 2002; 24: 111–120.
Shimoda M., Chеn S., Noduchi H., Matsumoto S., Gray- burn P.A. Neurogenic differentiation directs differentia- tion of cytokeratin 19 – positive human pancreatic no- nendocrine cells into insulin-producing cells. Transpl. Proc. 2010; 42 (6): 2071–2074.
Скалецкий НН, Кирсанова ЛА, Севастьянов ВИ. Раз- работка и экспериментальное исследование ткане- инженерных конструкций поджелудочной железы из культур островковых клеток поджелудочной железы и биодеградируемых носителей с целью стимуляции регенерации β-клеток у больных сахарным диабе- том. Трансплантология: итоги и перспективы. 2013; V: 140–152. Skaletskiy NN., Kirsanova LA., Sevastia- nov VI. Razrabotka i experimentalnoye issledovaniye tkaneinzhenernykh konstruktsiy podzheludochnoy zhe- lezy iz kultur ostrovkovykh kletok podzheludochnoy zhelezy i biodegradiruemykh nositeley s tselyu stimula- tsii regeneratsii β-kletok u bolnykh sakharnym diabetom. Transplantologia: itogi i perspektivy. 2013; V: 140–152.
Lee S-H, Hao E, Savinov AY, Geron I, Strong AJ, Itkin- Ansari P. Human B-cell precursors mature into func- tional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies. Trans- plantation. 2009; 87 (7): 983–991.
Smith RN, Kent SC, Nagle J, Selig M, Lafrate AJ, Naja- fian N et al. Pathology of an islet transplant 2 years after transplantation: evidence for anonimmunological loss. Transplantation. 2008; 86 (7): 54–62.
Page H, Flood P, Reynaud EG. Three-dimensional tis- sue cultures: current trendsand beyond. Cell Tissue Res. 2013; 352: 123–131.
Saito H, Takeuchi M, Chida K, Miyajima A. Generati- on of glucose-responsivefunctional islets with a three- dimensional structure from mouse fetal pancreatic cells and iPS cells in vitro. PLoS One. 2011; 6: e28209.
Daoud J, Asami K, Rosenberg L, Tabrizian M. Long- term in vitro human pancreatic islet culture using three dimensional microfabricated scaffolds. Biomaterials. 2011; 32: 1536–1542.
Zhao V, Song C, Zhang W. The three-dimensional nano- fiber scaffold culture condition improves viability and function of islets. J. Biomat. Res. A. 2010; 94 (3): 667– 672.
Kaufman-Francis K, Koffl er J, Weinberg N., Dor Y. & Levenberg S. Engineered vascular beds provide key sig- nals to pancreatic hormone-producing cells. PLoS One. 2012; 7: e40741.
Hall KK, Gattas-Asfura KM, Stabler CL. Microencapsu- lation of islets within alginate/poly (ethylene glycol) gels cross-linked via Staudinger ligation. Acta Biomat. 2011; 7: 614–624.
Mason MN, Mahoney MJ. Inhibition of Gamma-Secreta- se Activity Promotes Differentiation of Embryonic Pan- creatic Precursor Cells into Functional Islet-like Cluster- sin Poly(Ethylene Glycol) Hydrogel Culture. Tissue Eng. Part A. 2010; 16: 2593–2603.
Zhang Y, Jalili RB, Warnock GL., Ao Z, Marzban L, Gha- hary A. Three-dimensional scaffolds reduce islet amy- loid formation and enhance function of cultured human islets. Am. J. Pathol. 2012 Oct; 181 (4): 1296–1305.
Weber LM, He J, Bradley B., Haskins K, Anseth KS. PEG-based hydrogels as an in vitro encapsulation plat- form for testing controlled beta-cell microenvironments. Acta Biomater. 2006; 2: 1–8.
Cruise G, Hubbel J. In vitro and in vivo performance of porcine islets encapsulated in interfacially polymerized poly(ethylene glycol) diacrylate membranes. Cell Trans- plant. 1999; 8: 293–306.
Weber LM, Hayda KN, Haskins K, Anseth KS. The ef- fects of cell-matrixinteractions on encapsulated beta-cell function within hydrogels functionalized withmatrix-de- rived adhesive peptides. Biomaterials. 2007; 28: 3004– 3011.
Mason MN, Mahoney MJ. Selective beta-Cell Differen- tiation of Dissociated Embryonic Pancreatic Precursor Cells Cultured in Synthetic Polyethylene Glycol Hydro- gels. Tissue Eng. Part A. 2009; 15: 1343–1352.
Sabra G, Vermette P. A 3D cell culture system: separati- on distance between INS-1 cell and endothelial cell mo- nolayers co-cultured in fibrin influences INS-1 cells in- sulin secretion. Biotechnol. Bioeng. 2013; 110: 619–627.
Cheng JY, Raghunath M, Whitelock J, Poole-Warren L. Маtrix components and scaffolds for sustained islet function. Tissue Eng. Part B Rev. 2011. 17: 235–247.
Stendahl J., Kaufman D, Stupp S. Extracellular matrix in pancreatic islets: Relevance to scaffold design and trans- plantation. Cell Transplant. 2009; 18: 1–12.
Coronel M., Stabler C. Engineering a local microenvi- ronment for pancreatic islet replacement. Curr. Opin. Biotechnol. 2013; 24: 900–908.
Василец ВН. Методы изготовления матриксов. Био- совместимые материалы: учебное пособие. Под ред. В.И. Севастьянова, М.П. Кирпичникова. М.: МИА, 2011: 229–236. VasiletsVN. Metody izgotovleniya ma- trixov. Biosovmestimiye materialy: uchebnoye posobiye. Pod red. V.I. Sevastianova, M.P. Kirpichnikova. М.: МIА, 2011: 229–236.
Попов ВК. Имплантаты в заместительной и регене- ративной медицине костных тканей. 253–294. Po- pov VK. Implantaty v zamestitelnoy i regenerativnoy meditsine kostnykh tkaney. 253–294.
Hyne RO. The extracellular matrix: not just pretty fibrils.
Science. 2009; 326, 1216–1219.
Londono R, Badylak SF. Biologic Scaffolds for Rege- nerative Medicine: Mechanisms of in vivo Remodeling. Annals of Biomedical Engineering. March 2015; 43, Is- sue 3: 577–592.
Deijnen JHM., Hulstaert CE, Wolters GHJ, Schilfgaar- de R. Significance of theperi-insular extracellular matrix for islet isolation from the pancreas of rat, dog, pig, and man. Cell Tissue Res. 1992; 267: 139–146.
Jiang F-X, Harrison LC. Extracellular signals and pan- creatic beta-cell development: a brief review. Mol. Med. 2002; 8: 763–770.
Jiang F-X, Georges-Labouesse E, Harrison LC. Regula- tion of laminin 1-induced pancreatic beta-cell differen- tiation by alpha 6 integrin and alpha-dystroglycan. Mol. Med. 2001; 7: 107–114.
Pinkse GGM, Bouwman WP, Jiawan-Lalai R, Terpst- ra OT, Bruijn JA, Heer de E. Integrin signaling via RGD
peptides and anti-1 antibodies confers resistance to apo- ptosis in islets of Langerhans. Diabetes. 2006; 55: 1–6.
Ris F, Hammar E, Bosco D, Pilloud C, Maedler K, Do- nath MY et al. Impact of integrin-matrix matching and inhibition of apoptosis on the survival of purified human beta-cells in vitro. Diabetologia. 2002; 45: 841–850.
Hammar G, Parnaud D, Bosco E. Extracellular Matrix Protects Pancreatic beta-Cells Against Apoptosis. Dia- betes. 2004; 53: 2034–2041.
Deijnen JH, Snylichem Van M, Wolters Van PTR, Schilf- gaarde Van GHR. Cell & Tissue Distribution of colla- gens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res. 1994; 277: 115–121.
Hughes SJ, Clark A, McShane P, Contractor HH, Gray DW, Johnson PR. Characterisation of collagen VI within the islet-exocrine interface of the human pancre- as: implications for clinical islet isolation? Transplanta- tion. 2006; 8: 1. 423–426.
Cirulli V, Beattie GM, Klier G. Expression and function of alpha(v)beta(3) and alpha(v)beta(5) integrinsin the developing pancreas: roles in the adhesion and migration of putative endocrine progenitor cells. J. Cell Biol. 2000; 150: 1445–1460.
Kaido T, Yebra M, Cirulli V, Montgomery AM. Regula- tion of human beta-cell adhesion, motility, and insulin secretion by collagen IV and its receptor alpha1 beta1. J. Bio. Chem. 2004; 279: 53762–53769.
Yalili RB, Moeen-Rezakhanlou A, Hosseni-Tabatabaei A, Ao Z, Warnock GL. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islet required for diabetes reversal. J. Cell Physiol. 2011; 226 (7): 1813–1819.
Riopel M, Trinder M, Wang R. Fibrin, a scaffold material for islet transplantation and pancreatic endocrine tissue engineering. Tissue Eng. Part B Rev. 2014, Jul. 24 (Epub ahead of print).
Kuehn C, Lakey JR, Lamb MW, Vermette P. Young por- cine endocrine pancreatic islets cultured in fibrin show improved resistance toward hydrogen peroxide. Islets. 2013 Sep–Dec; 5 (5): 207–215. doi: 10.4161/isl.26989. Epub 2013 Nov.
Севастьянов ВИ, Перова НВ, Немец ЕА и др. При- меры экспериментально-клинического применения биосовместимых материалов в регенеративной ме- дицине. Биосовместимые материалы: учебное посо- бие. Под ред. В.И. Севастьянова, М.П. Кирпичникова. М.: МИА, 2011: 237–252. Sevastianov VI, Perova NV, Nemets EA i dr. Primery experimentalno-klinicheskogo primeneniya biosovmestimykh materialov v regenerativ- noy meditsine. Biosovmestimiye materialy: uchebnoye posobiye. Pod red. V.I. Sevastianova, M.P. Kirpichniko- va. М.: МIА, 2011: 237–252.
Fisher SA, Tam RY, Shoichet MS. Tissue mimetics: engi- neered hydrogel matrices provide biomimetic environ- ments for cell growth. Tissue Engineering. 2014; Part A. 20: 895–898.
Севастьянов ВИ, Перова НВ. Инъекционный гетеро- генный биополимерный гидрогель для заместитель- ной и регенеративной хирургии и способ его полу- чения. Патент РФ № 2433828 (2010). Sevastianov VI, Perova NV. Inyektsionniy geterogenniy biopolimerniy gidrogel dla zamestitelnoy i regenerativnoy khirurgii i sposob yego polucheniya. Patent RF 2433828 (2010).
3.Перова НВ, Севастьянов ВИ. Биополимерный гете- рогенный гидрогель Сферо®ГЕЛЬ – инъекционный биодеградируемый имплантат. Практическая меди- цина. 2014; 8 (84): 111–116. Perova NV, Sevastianov VI. Sfero®GEL – inyektsionniy biodegradiruyemiy implan- tat. Prakticheskaya meditsina. 2014; 8 (84): 111–116.
Chun S, Huang Y, Xie WJ, Hou Y, Huang RP, Song Y. Adhesive growth of pancreatic islet cells on a polygly- colic acid fibrous scaffold. Transplant. Proc. 2008; 40: 1658–1663.
Daoud J, Asami K, Rosenberg L, Tabrizian M. Long- term in vitro human pancreatic islet culture using three dimensional microfabricated scaffolds. Biomaterials. 2011; 32, 1536–1542.
Marchioli G, van Gurp L, van Krieken PP. Fabrica- tion of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation. Biofabrica- tion. 2015 May 28; 7 (2): 025009. doi: 10.1088/1758- 5090/7/2/025009.
Kaufman-Francis K, Koffler J, Weinberg N, Dor Y, Le- venberg S. Engineered vascularbeds provide key signals to pancreatic hormone-producing cells. PLoS One. 2012; 7: 740–741.
O'Connell PJ, Holmes-Walker DJ, Goodman D, Haw- thorne WJ, Loudovaris T, Gunton JE et al. Multicenter Australian Trial of Islet Transplantation: Improving Ac- cessibility and Outcomes. Am. J. Transplant. 2013; 13: 1850–1858.